Novo Nordisk’s Wegovy and copyright, both driven by semaglutide, have revolutionized obesity therapy by way of unparalleled weight loss outcomes.This led Novo Nordisk to conduct even further study into greater dosages of semaglutide especially for weight administration.Introduction This article discusses dosage factors and essential elements conc